Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients (Q42205529)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2014
edit
Language Label Description Also known as
English
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
scientific article published on September 2014

    Statements

    Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients (English)
    Alexandra U Scherrer
    Vincent Aubert
    Hans H Hirsch
    Pietro L Vernazza
    Rainer Weber
    1 September 2014
    2231-2239

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit